Target (CBDY) Exchange Rate Effect (2018 - 2026)
Target (CBDY) reported Exchange Rate Effect of -$5753.0 for Q1 2026, down 268.02% year-over-year from $3424.0 in Q1 2025, and down 483.53% quarter-over-quarter from $1500.0 in Q4 2025.
Target (CBDY) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Target (CBDY) has 9 years of Exchange Rate Effect data on file, last reported at -$5753.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$5753.0, down 268.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $47724.0 (up 149.75% YoY), and the FY2025 annual result was $56901.0, up 147.13% from the prior year.
- Exchange Rate Effect slipped to -$5753.0 in Q1 2026 per CBDY's latest filing, from $1500.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $62443.0 in Q2 2025 and troughed at -$106526.0 in Q4 2024.
- A 5-year average of -$3754.8 and a median of -$3379.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect soared 656.94% in 2023, then plunged 594.66% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $2845.0 in 2022, then soared by 656.94% to $21535.0 in 2023, then sank by 594.66% to -$106526.0 in 2024, then soared by 101.41% to $1500.0 in 2025, then sank by 483.53% to -$5753.0 in 2026.
- Business Quant data shows CBDY's Exchange Rate Effect at -$5753.0 in Q1 2026, $1500.0 in Q4 2025, and -$10466.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Target | - | - | 191,787.00 | -5,753.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,753.00 |
| Mar 31, 2026 | -5,753.00 |
| Dec 31, 2025 | 1,500.00 |
| Dec 31, 2025 | 1,500.00 |
| Sep 30, 2025 | -10,466.00 |
| Sep 30, 2025 | -10,466.00 |
| Jun 30, 2025 | 62,443.00 |
| Jun 30, 2025 | 62,443.00 |
| Mar 31, 2025 | 3,424.00 |
| Mar 31, 2025 | 3,424.00 |
| Dec 31, 2024 | -106,526.00 |
| Dec 31, 2024 | -106,526.00 |
| Sep 30, 2024 | 21,920.00 |
| Sep 30, 2024 | 21,920.00 |
| Jun 30, 2024 | -14,755.00 |
| Jun 30, 2024 | -14,755.00 |
| Mar 31, 2024 | -21,380.00 |
| Mar 31, 2024 | -21,380.00 |
| Dec 31, 2023 | 21,535.00 |
| Dec 31, 2023 | 21,535.00 |